Fig. 5.
Vaccination with Galα3LN-HSA+/−LMPLA induce T cell activation. Splenocytes were collected from mice immunized with Galα3LN-HSA or Galα3LN-HSA+LMPLA and immunized-challenged mice, followed by ex vivo stimulation with 20 μg/mL Galα3LN-HSA. a, b Percentage of antigen-specific CD4+ and CD8+ T cells, respectively, in immunized mice. c, d Percentage of CD4+ and CD8+ T cells, respectively, in immunized-challenged mice. e, f Percentage of memory CD4+CD44+ and CD8+CD44+ T cells, respectively, in immunized-challenged mice. One-way analysis of variance (ANOVA) compared with naive group was obtained for the immunized groups; Two-way ANOVA compared with the naive group was obtained for the immunized-challenged groups; *p < 0.05; **p < 0.01; ****p < 0.0001. Error bars indicate S.E.M. of triplicate determinations